Skip to content

ABUS

Arbutus Biopharma Corp

NASDAQ · Healthcare · Biotechnology · US

$4.06
+4.64%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
5.31x
P/E 2027E
—
P/E 2028E
—
P/S forward
201.08x

Trailing multiples

Trailing twelve months

P/E TTM
5.14x
PEG TTM
—
Price / book
3.11x
Price / sales
4.43x
Price / cash flow
-32.66x

Enterprise value

Enterprise value
$715.3M
EV / sales
3.94x
EV / EBITDA
4.67x
EV / EBIT
4.86x
Market cap
$804.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026